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spp.)  that  cohabitated  the  pond,  but 
showed no external signs of disease, 
were positive for ranavirus by PCR us-
ing primers M153 and M154. Further 
sequence  analyses  are  ongoing,  and 
additional investigations of other am-
phibians and fishes are needed.
Live  freshwater  fish  from  sev-
eral  countries  have  been  imported 
into  Japan.  However,  large  amounts 
(<1,300 tons in 2007) of live aquacul-
ture products, including eels and other 
fishes, have been imported from Tai-
wan  into  Japan  (www.customs.go.jp/
tariff/2007_4/data/03.htm). Given that 
viruses that originate in Japan and Tai-
wan are similar, the ranavirus we de-
tected was likely imported into Japan 
in an infected aquatic organism. How-
ever, an epidemiologic survey will be 
necessary to determine the source of 
the ranavirus in the pond studied. Like-
wise, this virus may be endemic to Ja-
pan, and a survey of native and foreign 
free-ranging  amphibians  should  be 
conducted. Molecular analysis of rana-
viruses detected in these surveys will 
be necessary to differentiate endemic 
viruses from introduced viruses.
Japan  is  located  at  middle  lati-
tudes and has a temperate climate. This 
country has long been geologically iso-
lated from Asia. This isolation has re-
sulted in the development of many di-
verse species of amphibians in Japan; 
23 species of the order Caudata and 35 
species of the order Anura. Of these 
species, 49 (84%) are native and 36 
(62%) are listed by the Ministry of the 
Environment as threatened species (8). 
R. catesbeiana frogs were introduced 
into Japan in 1918 as a food animal, 
and raising them by aquaculture was 
widely  attempted. Although  they  are 
no  longer  cultured,  feral  populations 
have  become  established  throughout 
Japan (9). Ranavirus in R. catesbeiana 
frogs represents a serious threat to am-
phibians throughout Japan.
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Maternal Antibody 
Transfer in  
Yellow-legged Gulls
To  the  Editor: Avian  influenza 
viruses  (AIVs)  are  emerging  patho-
gens  of  concern  because  they  can 
cause deaths in birds and humans (1). 
Although wild birds likely contribute 
to AIV  emergence  because  they  are 
the  natural  reservoir  for  all  known 
influenza virus subtypes (1), our un-
derstanding of AIV transmission and 
immunology in natural avian popula-
tions is incomplete (2). In this context, 
the transfer of maternal antibodies is 
a tool that should be used more often 
in immunologic analysis. Because an-
tibodies  in  eggs  and  hatchlings  can 
reflect the mother’s past exposure to 
pathogens  (3,4)  and  both  life  stages 
are more easily sampled than adults, 
quantifying antibodies found in avian 
young could help clarify AIV epide-
miology.
We determined whether eggs of 
yellow-legged  gulls  (Larus  micha-
hellis)  contained  antibodies  against 
AIVs.  Yellow-legged  gulls  can  host 
AIVs (C. Lebarbenchon, unpub. data), 
are abundant, and nest in large, dense 
colonies  in  coastal  areas.  In  April 
2008, we collected 466 eggs from 2 
yellow-legged  gull  colonies  located 
on the Mediterranean coast: 252 eggs 
from Gruissan (43.1099°N, 3.1071°E; 
350 breeding pairs over 1.5 hectares), 
and 212 from Villeneuve-lès-Mague-
lone  (VLM;  43.4895°N,  3.8520°E; 
400 pairs over 1 hectare). Villeneuve 
nests  formed  2  spatially  clustered 
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subcolonies:  VLM1  (129  eggs)  and 
VLM2  (83  eggs). We  also  collected 
global positioning system coordinates 
for VLM1 nests.
Egg yolks were isolated and fro-
zen at –20°C until analysis. Antibod-
ies were obtained by using chloroform 
extraction (4). The yolk was diluted 
1:1 in phosphate-buffered saline and 
homogenized.  An  equal  volume  of 
chloroform  was  added,  the  solution 
was  centrifuged  (6,000  ×  g  for  15 
min), and the supernatant was used in 
the analyses.
Extracts were tested for antibod-
ies  against  the  AIV  nucleoprotein 
by  using  a  commercial  competitive 
ELISA  (IDEXX/Institut  Pourquier, 
Montpellier,  France).  The  assay  has 
been validated by using seagull serum 
(IDEXX,  pers.  comm.)  and  chicken 
egg yolk (5). A subset of samples was 
tested by using a second commercial 
competitive ELISA (IDVet, Montpel-
lier,  France).  Optical  density  values 
obtained in the 2 assays were signifi-
cantly correlated (r = 0.90, df = 39, 
p<0.001), and serostatus was consis-
tent across assays.
Overall antibody prevalence was 
14% (65/466), indicating exposure to 
influenza A viruses in these colonies. 
As expected, antibody prevalence in 
gulls  is  higher  than  the  viral  preva-
lence previously estimated by reverse 
transcription–PCR  or  virus  isolation 
on  fecal  samples,  i.e.,  the  methods 
typically used by avian influenza sur-
veillance networks. A spring and sum-
mer survey performed on feces from 
gulls of the Camargue region (east of 
our colonies) showed that only 0.9% 
of gulls (2 infected of 228 sampled) 
were  excreting  AIVs  (C.  Lebarben-
chon, unpub. data).
Egg antibody prevalence did not 
differ significantly between colonies. 
The  antibody  prevalence  of  13.5% 
found  at  Gruissan  (34  of  252  eggs) 
was comparable with the 14.5% found 
at Villeneuve (31 of 214 eggs) (gen-
eralized  linear  model  with  binomial 
distribution, z = 0.4, p = 0.8). The sub-
colonies of Villeneuve also did not dif-
fer: 18/129 (14%) in VLM1 compared 
with  12/83  (14.5%)  in  VLM2  (z  = 
0.02, p = 0.9). There was no evidence 
of spatial autocorrelation in the distri-
bution of antibody in eggs by using the 
Moran I spatial statistic. This similar-
ity of antibody prevalence across and 
within colonies suggests that exposure 
is dictated by regional rather than local 
conditions, a hypothesis that should be 
tested  by  sampling  across  a  broader 
range of nest densities and over time.
Our study presents evidence for 
the  presence  of  antibodies  against 
AIVs in wild bird eggs, and the find-
ings have important practical implica-
tions. The difference in prevalence es-
timated from virus isolation (0.9%) and 
antibody  detection  (14%),  although 
expected, highlights the complemen-
tary nature of the 2 approaches. Most 
surveys estimate current infection by 
virus isolation, which provides infor-
mation about disease risk in addition 
to phylogeographic tracking of strains. 
In  contrast,  information  on  antibody 
prevalence,  which  shows  past  and 
present population exposure and risk, 
has largely been ignored with few ex-
ceptions (e.g., 6,7). Future work could 
benefit from using both approaches in 
tandem with modeling to develop an 
understanding of avian influenza ecol-
ogy in nature.
Our results also show the gener-
alizable potential of maternal antibody 
transfer for tracking pathogen exposure 
in wild birds, notably in the case of rec-
ognized  emerging  zoonoses.  Because 
eggs  and  hatchlings  are  proxies  of 
past and present adult pathogen expo-
sure (3,4), the difficult and sometimes 
disruptive  sampling  of  adults  can  be 
circumvented by the rapid and cost-ef-
ficient sampling of their young, which 
will facilitate monitoring efforts. Due 
to the high intranest correlation in egg 
antibodies (4), only partial sampling of 
clutches (e.g., 1 of 3 eggs) is necessary 
to track pathogen presence and preva-
lence  through  space  and  time.  The 
sampling effects could further be mini-
mized by taking blood samples from 
young nestlings of a standardized age. 
Finally, such samples provide abundant 
material for the simultaneous surveil-
lance of other emerging pathogens of 
interest,  such  as  Campylobacter  spp. 
(8) and West Nile virus (9).
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Prevalence of  
Human Bocavirus 
in Human Tonsils 
and Adenoids
To the Editor: Recently, Longtin 
et al. (1) reported a high rate (43%) of 
human bocavirus (HBoV) infection in 
a group of children chosen to serve as 
controls in a study of HBoV preva-
lence among hospitalized children and 
adults.  In  contrast,  previous  reports 
had found low HBoV prevalence rates 
of 0%–1% in control groups (2,3). At-
tempting to explain this surprising dif-
ference in rates, Lu et al. (4) suggested 
that selection of control patients may 
be related to the difference in rates. 
The control group used in the Long-
tin study was primarily (71%) made 
up  of  children  undergoing  elective 
surgery; previous studies had selected 
control groups from other sources, in-
cluding well children on routine visits 
and  outpatients  with  nonrespiratory 
symptoms. Because the Longtin study 
surgeries were mainly tonsillectomies, 
adenoidectomies, and myringotomies, 
Lu et al. examined the possibility that 
tonsillar tissues, which include the ad-
enoids, are sites of persistent HBoV 
infection. When these researchers ex-
tracted  DNA  from  tonsillar  lympho-
cytes obtained from pediatric patients 
who had undergone tonsillectomies or 
adenoidectomies, they detected HBoV 
DNA in 32% of the samples (4). These 
findings  strongly  suggest  a  connec-
tion between HBoV and tonsillar tis-
sue. Therefore, we tested a number of 
tonsillar samples for the presence of 
HBoV DNA.
Sample acquisition was approved 
by the Nationwide Children’s Hospi-
tal Institutional Review Board. Tonsils 
and adenoids were obtained from 91 
patients who underwent elective sur-
gery  at  Nationwide  Children’s  Hos-
pital  from  June  through  September 
2004. Patients’ ages ranged from 1 to 
16 years (median 5.9 years; age was 
unknown for 4 patients).
Samples  consisted  of  surgically 
removed  tonsil  or  adenoid  tissues. 
DNA was extracted and its concentra-
tion was determined as previously de-
scribed (5). Two primer sets were used 
for HBoV detection by using real-time 
PCR with SYBR Green detection and 
melting-point  determination.  We  de-
signed primers 3097F (5′-GTC-CAA-
TTA-CAT-GAT-CAC-GCC-TAC-TC) 
and 3420R (5′-TGC-GTC-CAC-AGT-
ATC-AGG-TTG-TTG)  that  targeted 
the viral protein 1/2 (VP1/VP2) region 
of  HBoV.  The  nonstructural  protein 
1  (NP1)  region  was  targeted  by  us-
ing primers 188F and 542R from Al-
lander et al. (6) Each 20-μL reaction 
contained SYBR Green JumpStart Taq 
ReadyMix  (Sigma,  St.  Louis,  MO, 
USA), 4 mmol/L MgCl2, 250 nmol/L 
primers, double-distilled H2O, and 2 μL 
of DNA (50–200 ng) cycled on an ABI 
PRISM 7900HT (Applied Biosystems, 
Foster City, CA, USA) instrument at 
94oC for 2 min, followed by 40 cycles 
of 94°C for 20 s, 60°C (NP1 primers) 
or 68°C (VP1/VP2 primers) for 20 s, 
and 72°C for 14 s. Amplification and 
melting  curves  were  analyzed  with 
7900HT version 2.2.1 software (Ap-
plied  Biosystems);  positive  samples 
were  verified  by  sequence  analysis. 
Sequenced  VP-  and  NP1-generated 
amplicons were 99%–100% identical 
to HBoV strain ST1 (6). The detec-
tion sensitivities of the VP and NP1 
assays, determined by using a plasmid 
construct  containing  the  full  HBoV 
genome, were 1–5 and 5–10 gene cop-
ies/reaction, respectively.
Our  testing  identified  HBoV 
DNA in 5 (5.5%) of the 91 children 
who  underwent  elective  tonsillecto-
my/adenoidectomy. Ages ranged from 
1.9 to 4.6 years (median 3.4 years). 
The reason for the much lower HBoV 
prevalence in this group of children, 
compared with prevalences found in 
studies by Longtin et al. and Lu et al., 
is unclear. Lu et al. (4) reported a much 
higher  HBoV  rate  of  lymphocytes 
from adenoids (56%) than from ton-
sils (16%). Although we did not know 
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